• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA FGD5-AS1 通过靶向 miR-506-3p/RAB3D 轴增强骨肉瘤细胞的增殖和迁移。

Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.

机构信息

Department of Orthopedics, People's Hospital of Rizhao, Affiliated to Clinical Hospital of Jining Medical University, 126 Tai'an Road, Xinshi District, Rizhao, 276800, Shandong, China.

People's Hospital of Rizhao, 126 Taian Rd, Donggang District, Rizhao, Shandong, China.

出版信息

Hum Cell. 2021 Jul;34(4):1255-1265. doi: 10.1007/s13577-021-00536-w. Epub 2021 Apr 23.

DOI:10.1007/s13577-021-00536-w
PMID:33891267
Abstract

Osteosarcoma (OSA), the malignant bone tumor, predominantly affecting children and adolescents, threatens the life and life quality of the patients. An increasing number of studies have indicated the role of long non-coding RNA (lncRNA) dysregulation in cancer biology. Herein, the study was aimed to explore the role of FGD5 antisense RNA 1 (FGD5-AS1), a lncRNA, in OSA. Expression levels of FGD5-AS1, miR-506-3p and RAB3D mRNA were quantified utilizing qRT-PCR. The expression of RAB3D protein was examined employing Western blot. A series of functional experiments including CCK-8 assay, BrdU assay, wound healing assay, Transwell assay were performed for studying the effects of FGD5-AS1 on the malignancy of OSA cell lines 143B and HOS. The binding site between miR-506-3p and FGD5-AS1 was identified and validated by luciferase reporter assay and RNA immunoprecipitation assay. It was demonstrated that the expression of FGD5-AS1 was up-regulated in OSA tissues and cell lines, and its high expression is associated with higher Enneking stage and poorer histological differentiation. Gain-of-function and loss-of-function studies suggested that FGD5-AS1 facilitated OSA cells proliferation and migration. The promoting effects of FGD5-AS1 overexpression on OSA cell proliferation and migration could be counteracted by miR-506-3p. Moreover, FGD5-AS1 competitively adsorbed miR-506-3p to repress its expression so as to up-regulate the expression of RAB3D. These results indicate that FGD5-AS1 is capable of expediting OSA cell proliferation and migration via sponging miR-506-3p to up-regulate RAB3D.

摘要

骨肉瘤(OSA)是一种主要影响儿童和青少年的恶性骨肿瘤,威胁着患者的生命和生活质量。越来越多的研究表明长链非编码 RNA(lncRNA)失调在癌症生物学中的作用。在此,本研究旨在探讨 lncRNA FGD5 反义 RNA 1(FGD5-AS1)在 OSA 中的作用。利用 qRT-PCR 定量检测 FGD5-AS1、miR-506-3p 和 RAB3D mRNA 的表达水平。采用 Western blot 检测 RAB3D 蛋白的表达。通过 CCK-8 assay、BrdU assay、划痕愈合 assay、Transwell assay 等一系列功能实验研究 FGD5-AS1 对 OSA 细胞系 143B 和 HOS 恶性表型的影响。通过荧光素酶报告基因 assay 和 RNA 免疫沉淀 assay 鉴定和验证 miR-506-3p 与 FGD5-AS1 之间的结合位点。结果表明,FGD5-AS1 在 OSA 组织和细胞系中表达上调,其高表达与更高的 Enneking 分期和较差的组织学分化相关。功能获得和功能丧失研究表明,FGD5-AS1 促进 OSA 细胞增殖和迁移。FGD5-AS1 过表达对 OSA 细胞增殖和迁移的促进作用可以被 miR-506-3p 逆转。此外,FGD5-AS1 通过竞争性吸附 miR-506-3p 来抑制其表达,从而上调 RAB3D 的表达。这些结果表明,FGD5-AS1 通过海绵吸附 miR-506-3p 来上调 RAB3D,从而加速 OSA 细胞的增殖和迁移。

相似文献

1
Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.长链非编码 RNA FGD5-AS1 通过靶向 miR-506-3p/RAB3D 轴增强骨肉瘤细胞的增殖和迁移。
Hum Cell. 2021 Jul;34(4):1255-1265. doi: 10.1007/s13577-021-00536-w. Epub 2021 Apr 23.
2
EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.EBF1 通过作为 ceRNA 调节 miR-124-3p/G3BP2 轴上调 lncRNA FGD5-AS1 促进骨肉瘤进展。
J Orthop Surg Res. 2022 Jun 27;17(1):332. doi: 10.1186/s13018-022-03181-7.
3
LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.长链非编码RNA FGD5-AS1/微小RNA-5590-3p轴通过ERK/AKT信号通路促进肾细胞癌的增殖和转移。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):8756-8766. doi: 10.26355/eurrev_202009_22814.
4
LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma.长链非编码 RNA FGD5-AS1 通过调控 miR-154-5p/WNT5A 轴增强骨肉瘤细胞自噬相关阿霉素耐药性。
Cell Biol Int. 2022 Nov;46(11):1937-1946. doi: 10.1002/cbin.11889. Epub 2022 Aug 30.
5
LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.长链非编码 RNA FGD5-AS1 通过靶向 miR-142-5p 促进卵巢癌细胞的恶性表型。
Apoptosis. 2021 Jun;26(5-6):348-360. doi: 10.1007/s10495-021-01674-0. Epub 2021 May 11.
6
LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.长链非编码 RNA FGD5-AS1 通过海绵吸附 miR-153-3p 调控 MCL1 促进口腔癌细胞生长。
Aging (Albany NY). 2020 Jul 16;12(14):14355-14364. doi: 10.18632/aging.103476.
7
Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.长链非编码 RNA FGD5-AS1 通过海绵吸附 miR-302e 上调 CDCA7 促进结直肠癌细胞增殖、迁移和侵袭。
In Vitro Cell Dev Biol Anim. 2019 Sep;55(8):577-585. doi: 10.1007/s11626-019-00376-x. Epub 2019 Jul 22.
8
Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.长链非编码 RNA FGD5-AS1 的沉默通过调节 miR-493-5p/DDX5 轴抑制非小细胞肺癌的进展。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821990007. doi: 10.1177/1533033821990007.
9
LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.长链非编码 RNA ADPGK-AS1 通过靶向 miR-542-3p 调控骨肉瘤细胞的增殖、侵袭、迁移和凋亡。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8751-8760. doi: 10.26355/eurrev_201910_19269.
10
The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.长非编码 RNA 锌指 E 盒结合同源盒 2 反义 RNA 1 通过调控 miR-145 促进骨肉瘤癌细胞增殖、抑制凋亡和增加迁移的作用及临床意义。
Anticancer Drugs. 2021 Feb 1;32(2):168-177. doi: 10.1097/CAD.0000000000000984.

引用本文的文献

1
Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications.微小RNA-506在癌症治疗中的治疗潜力:作用机制及治疗意义
Front Oncol. 2025 Apr 3;15:1524763. doi: 10.3389/fonc.2025.1524763. eCollection 2025.
2
Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity.铜死亡相关长链非编码RNA特征作为骨肉瘤免疫中的一种预后和治疗生物标志物。
Sci Rep. 2025 Jan 2;15(1):221. doi: 10.1038/s41598-024-84024-9.
3
The prognostic significance of lncRNA FGD5-AS1 in various malignancies: a meta-analysis.

本文引用的文献

1
LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity.长链非编码 RNA SPRY4-IT1 通过海绵吸附 miR-101 活性调控 ZEB1 和 ZEB2 表达促进骨肉瘤进展。
Int J Oncol. 2020 Jan;56(1):85-100. doi: 10.3892/ijo.2019.4910. Epub 2019 Nov 13.
2
Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.MALAT1基因敲低通过调控miR-34a/细胞周期蛋白D1轴抑制骨肉瘤进展。
Int J Oncol. 2019 Jan;54(1):17-28. doi: 10.3892/ijo.2018.4600. Epub 2018 Oct 19.
3
MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.
长链非编码RNA FGD5-AS1在各种恶性肿瘤中的预后意义:一项荟萃分析。
Front Oncol. 2024 Aug 19;14:1451949. doi: 10.3389/fonc.2024.1451949. eCollection 2024.
4
Osteosarcoma in a ceRNET perspective.中枢神经系统外尤文肉瘤的临床特征。
J Biomed Sci. 2024 Jun 5;31(1):59. doi: 10.1186/s12929-024-01049-y.
5
Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells.miR-506-3p的过表达逆转了耐药骨肉瘤细胞中的阿霉素耐药性。
Front Pharmacol. 2024 Feb 14;15:1303732. doi: 10.3389/fphar.2024.1303732. eCollection 2024.
6
LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance.长链非编码RNA在骨肉瘤治疗中可能发挥至关重要的作用:抑制骨肉瘤进展并提高化疗耐药性。
Front Genet. 2023 Jan 16;13:1022155. doi: 10.3389/fgene.2022.1022155. eCollection 2022.
7
Exosome-Transmitted miR-506-3p Inhibits Colorectal Cancer Cell Malignancy via Regulating GSTP1.外泌体传递的 miR-506-3p 通过调控 GSTP1 抑制结直肠癌细胞恶性表型。
Appl Biochem Biotechnol. 2023 Mar;195(3):2015-2027. doi: 10.1007/s12010-022-04268-x. Epub 2022 Nov 19.
8
The role of long non-coding RNA FGD5-AS1 in cancer.长链非编码 RNA FGD5-AS1 在癌症中的作用。
Bioengineered. 2022 Apr;13(4):11026-11041. doi: 10.1080/21655979.2022.2067292.
9
lncRNA FGD5-AS1 Regulates Bone Marrow Stem Cell Proliferation and Apoptosis by Affecting miR-296-5p/STAT3 Axis in Steroid-Induced Osteonecrosis of the Femoral Head.长链非编码 RNA FGD5-AS1 通过影响 miR-296-5p/STAT3 轴调控激素诱导性股骨头坏死骨髓间充质干细胞增殖和凋亡。
J Healthc Eng. 2022 Feb 12;2022:9364467. doi: 10.1155/2022/9364467. eCollection 2022.
10
FGD5-AS1 facilitates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting the miR-506-3p/BMP7 axis.FGD5-AS1 通过靶向 miR-506-3p/BMP7 轴促进人骨髓间充质干细胞的成骨分化。
J Orthop Surg Res. 2021 Nov 12;16(1):665. doi: 10.1186/s13018-021-02694-x.
微小 RNA-505 在人骨肉瘤中下调,并调节细胞增殖、迁移和侵袭。
Oncol Rep. 2018 Feb;39(2):491-500. doi: 10.3892/or.2017.6142. Epub 2017 Dec 11.